Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05177848 · ClinicalTrials.gov registry record · NA
Comparison of the Substitution Between Different Tobacco/Nicotine Products as a Function of Tobacco-user Type
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05177848: Completed NA study, sponsored by Virginia Polytechnic Institute and State University.
NCT05177848 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05177848, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.
Primary Outcome
Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price. Other product prices in the ETM will depend on the experimental condition. The degree to which other nicotine/tobacco products substitute for conventional cigarettes as a function of novel product (e.g. nicotine vaping products, heated tobacco products, nicotine pouch products) prices will be assessed. To obtain estimates of substitution of price-constant products in th
Interventions
- OTHER All nicotine/ tobacco products at market price
- OTHER Nicotine vaping products at 1/2 market price
- OTHER Heated tobacco products at 1/2 market price.
- OTHER Nicotine vaping products at 2x market price
- OTHER Heated tobacco products at 2x market price.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-06-29 |
| Est. Completion | 2023-06-07 |
| Phase | NA |
What the finished NCT05177848 record still lists
NCT05177848 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 5 interventions - of which All nicotine/ tobacco products at market price is the first listed.
NCT05177848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05177848 about?
NCT05177848 is a clinical study titled "Comparison of the Substitution Between Different Tobacco/Nicotine Products as a Function of Tobacco-user Type". This study will investigate the relative appeal (abuse liability) of novel tobacco products, how the appeal is modulated by relative price, user type, and how novel products may substitute for one another.
What is the current status of trial NCT05177848?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-06-29. Estimated completion is 2023-06-07.
What interventions are being tested in trial NCT05177848?
The interventions under investigation include: All nicotine/ tobacco products at market price (OTHER), Nicotine vaping products at 1/2 market price (OTHER), Heated tobacco products at 1/2 market price. (OTHER), Nicotine vaping products at 2x market price (OTHER), Heated tobacco products at 2x market price. (OTHER).
Who is sponsoring clinical trial NCT05177848?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05177848's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI